Cannagistics Inc.

2022 Q2 Form 10-Q Financial Statement

#000166357722000430 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.00 $560.00 $2.160K
YoY Change -99.7% -13.85% -34.55%
Cash & Equivalents $104.00
Short-Term Investments
Other Short-Term Assets $25.00K $25.00K $25.00K
YoY Change 8.55%
Inventory
Prepaid Expenses $25.00K
Receivables
Other Receivables
Total Short-Term Assets $81.60K $58.06K $67.16K
YoY Change 145.94% 8832.31% 155.07%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $81.60K $58.06K $67.16K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $81.60K $58.06K $67.16K
YoY Change 121.69% 1256.54% 18.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.403M $1.278M $1.167M
YoY Change 45.5% 48.32% 56.13%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $4.396M $4.123M $3.443M
YoY Change 53.38% 35.94% 16.71%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.706M $6.363M $5.196M
YoY Change 53.04% 36.3% 16.2%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $837.8K
YoY Change -100.0% -3.87%
Total Long-Term Liabilities $0.00 $0.00 $837.8K
YoY Change -100.0% -100.0% -3.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.706M $6.363M $5.196M
Total Long-Term Liabilities $0.00 $0.00 $837.8K
Total Liabilities $6.706M $6.363M $6.033M
YoY Change 28.48% 15.56% 12.93%
SHAREHOLDERS EQUITY
Retained Earnings -$32.35M
YoY Change
Common Stock $266.4K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) -$45.00K
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.624M -$6.305M -$5.884M
YoY Change
Total Liabilities & Shareholders Equity $81.60K $58.06K $67.16K
YoY Change 121.69% 1256.54% 18.66%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Notes Receivable Net
NotesReceivableNet
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2021Q2 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001304741
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2022Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
CY2021Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
CY2022Q2 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CNGT Settlement Fees On Conversion Of Stock
SettlementFeesOnConversionOfStock
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
us-gaap Proceeds From Loans
ProceedsFromLoans
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CNGT Original Issuance Discount On Promissory Notes Payable
OriginalIssuanceDiscountOnPromissoryNotesPayable
usd
CNGT Original Issuance Discount On Promissory Notes Payable
OriginalIssuanceDiscountOnPromissoryNotesPayable
usd
CNGT Conversion Of Common Stock Payable
ConversionOfCommonStockPayable
usd
CNGT Conversion Of Common Stock Payable
ConversionOfCommonStockPayable
usd
CY2022Q2 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
32353128 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
usd
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Motor Parkway
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
266424608 shares
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3911779
CY2022Q2 us-gaap Cash
Cash
104 usd
dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55711
dei Entity Registrant Name
EntityRegistrantName
Cannagistics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 401
dei Entity Address City Or Town
EntityAddressCityOrTown
Hauppauge
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11788
dei City Area Code
CityAreaCode
631
dei Local Phone Number
LocalPhoneNumber
787-8455
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2021Q3 us-gaap Cash
Cash
30007 usd
CY2022Q2 us-gaap Notes Receivable Net
NotesReceivableNet
56500 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25000 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1145788 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
81604 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
45007 usd
CY2022Q2 us-gaap Assets
Assets
81604 usd
CY2021Q3 us-gaap Assets
Assets
45007 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1402755 usd
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1058606 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
520000 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
520000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
195028 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
301537 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3281205 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2329996 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
69680 usd
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
529171 usd
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
594331 usd
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
416159 usd
CY2022Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
837778 usd
CY2021Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
837778 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6705749 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5691710 usd
CY2022Q2 us-gaap Liabilities
Liabilities
6705748 usd
CY2021Q3 us-gaap Liabilities
Liabilities
5691710 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
266424 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5646703 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81604 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45007 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
266424608 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
266424608 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189561572 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189561572 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
189561 usd
CY2022Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
290000 usd
CY2021Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
290000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25212259 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24485627 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
-45000 usd
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
-45000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32353128 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-30572191 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6624145 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12139 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20717 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55417 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36533 usd
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21759 usd
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21759 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65277 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
43518 usd
CY2022Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2898 usd
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3025 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12813 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10511 usd
CY2022Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
15000 usd
CY2021Q2 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
9625 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
698979 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
38125 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
24438 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
64766 usd
us-gaap Professional Fees
ProfessionalFees
239165 usd
us-gaap Professional Fees
ProfessionalFees
147650 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
76234 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
119892 usd
us-gaap Operating Expenses
OperatingExpenses
1071651 usd
us-gaap Operating Expenses
OperatingExpenses
276337 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-76234 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1391978 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
164337 usd
us-gaap Interest Expense
InterestExpense
1010892 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
262246 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
709286 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-119892 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1071651 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-276337 usd
CY2022Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
21759 usd
CY2021Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
21759 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
65277 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
43518 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
319263 usd
us-gaap Interest Expense
InterestExpense
311971 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-48000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-25000 usd
CY2021Q2 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-241835 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
123822 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-1177910 usd
CY2022Q2 CNGT Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-54228 usd
CY2021Q2 CNGT Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-122167 usd
CNGT Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-160507 usd
CNGT Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-79385 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
243276 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-319510 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-382138 usd
us-gaap Net Income Loss
NetIncomeLoss
-1780937 usd
us-gaap Net Income Loss
NetIncomeLoss
-1668315 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.00
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
266424608 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
160806048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239242161 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131902229 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5646703 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
269432 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
377604 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-884359 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5884026 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
156459 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-577068 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-6304635 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-319510 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6624145 usd
CNGT Penalty On Convertible Note Payable
PenaltyOnConvertibleNotePayable
48000 usd
CNGT Penalty On Convertible Note Payable
PenaltyOnConvertibleNotePayable
25000 usd
CNGT Net Loss
NetLoss
-1780937 usd
CNGT Net Loss
NetLoss
-1668315 usd
CNGT Settlement Fees On Conversion Of Stock
SettlementFeesOnConversionOfStock
13000 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-123822 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
513750 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-160507 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
584775 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
83176 usd
us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
1010892 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
377604 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-56500 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
344149 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
253387 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
173172 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-177949 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-195227 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
557500 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
133000 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
5000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
68330 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
96789 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
422478 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
60306 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
34600 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
148046 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
195189 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29903 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30007 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
685 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
647 usd
CNGT Original Issuance Discount On Convertible Notes Payable
OriginalIssuanceDiscountOnConvertibleNotesPayable
225159 usd
CNGT Original Issuance Discount On Convertible Notes Payable
OriginalIssuanceDiscountOnConvertibleNotesPayable
12000 usd
CNGT Conversion Of Notes Payable Fees And Derivative Liabilities
ConversionOfNotesPayableFeesAndDerivativeLiabilities
234330 usd
CNGT Conversion Of Notes Payable Fees And Derivative Liabilities
ConversionOfNotesPayableFeesAndDerivativeLiabilities
802731 usd
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The DEF14C Information Statement set out the plan of the Company to amend its name to The Integrity Wellness Group, Inc., or some other similar name, and to effectuate a reverse stock split of its common stock of one (1) new share of common stock for each forty (40) old shares of common stock. The corporate action change has been submitted to FINRA on October 29, 2021, and the Company is awaiting a response.
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
520000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84A_eus-gaap--UseOfEstimates_zy3v1VZOJEF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
69680 usd
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
529171 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2021Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
54475 usd
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
57064 usd
CY2019Q4 us-gaap Assets Sold Under Agreements To Repurchase Market Value
AssetsSoldUnderAgreementsToRepurchaseMarketValue
54296 usd
CY2019Q4 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
10 usd
CY2021Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
520000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
520000 usd
CY2021Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
520000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11041 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11035 usd
CY2021Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
3051233 usd
CY2020Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2631533 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
311359 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
69682 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
11406 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
3065 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
594331 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
416159 usd
CY2018Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1034000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
153217 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
65277 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
65277 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
266424608 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189561572 shares
CY2022Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
290000000 shares
CY2021Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
290000000 shares
CY2021Q3 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P6M
us-gaap Lease Cost
LeaseCost
1200 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
usd
CY2021Q3 us-gaap Due From Related Parties
DueFromRelatedParties
usd

Files In Submission

Name View Source Status
0001663577-22-000430-index-headers.html Edgar Link pending
0001663577-22-000430-index.html Edgar Link pending
0001663577-22-000430.txt Edgar Link pending
0001663577-22-000430-xbrl.zip Edgar Link pending
cngt-20220430.xsd Edgar Link pending
cngt-20220430_cal.xml Edgar Link unprocessable
cngt-20220430_def.xml Edgar Link unprocessable
cngt-20220430_lab.xml Edgar Link unprocessable
cngt-20220430_pre.xml Edgar Link unprocessable
cngt10q.htm Edgar Link pending
cngt10q_htm.xml Edgar Link completed
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending